Ann: Notice of Extraordinary General Meeting/Proxy Form, page-87

The market has now priced in the Nasdaq listing as a sure thing. 28 cents is what the market currently thinks GMV is worth with that information in hand. Surely many in the medical field are at least peripherally aware of our offerings, so where is the hype? Where is the explosive growth in new deals being announced? When was the last time you saw an article about the Prizma or the patch? Are Australian investors so dumb they don't know a bargain when they see one, or are they just as smart as their American peers? Not down-ramping, just playing devil's advocate.